Pre-menstrual Syndrome Treatment Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: October 24, 2020 |

The global pre-menstrual syndrome treatment market size is projected to grow at the CAGR of over 3% market during the forecast period 2020 to 2027 and accounted for around USD 1.5 billion in 2019. Pre-menstrual syndrome (PMS) is a medical condition in women that occurs during childbearing age. It is estimated that more than one in three women suffers from PMS; and one in every twenty women demonstrates life disturbing symptoms. PMDD occurs in 3% to 5% of menstruating women. Though the exact cause of PMS is unknown, it is reported that fluctuating levels of hormones (estrogen and progesterone) are related to PMS symptoms. The treatment regimen of PMS is temporary i.e. administered only for symptom management before the onset of the menstrual cycle. Education, nutrition, exercise, and medication together form the complete layout of the PMS treatment module.

Market Insights:

Pre-menstrual syndrome (PMS) is defined as a condition that affects women at childbearing age and is characterized by symptoms such as bloating, pain, breast tenderness, body pain, fatigue, mood fluctuation, anxiety, etc. where the exact cause of PMS is unknown. According to the American Psychiatric Association, U.S. almost 90% of women of childbearing age experience premenstrual symptoms, and less than 10% are diagnosed with premenstrual dysphoric disorder (PMDD). Government and non-government agencies’ campaigns towards elevating the status of female health and education have attributed to significant growth in demand for female hygiene products and also PMS treatment drugs. Further growth in female education and the number of working female population will contribute to the demand for PMS drugs in the region.

Market Segment Insights:

The global pre-menstrual syndrome treatment market is segmented by drug type as analgesics (pain killers), oral contraceptive pills (OCPs), gonadotropin-releasing hormone (GnRH), antidepressants, ovarian suppressors, diuretics, and benzodiazepines. Common painkillers available for treating PMS are NSAIDS and paracetamol. This segment is majorly dominated by over-the-counter drugs that are cheap and easily available in the market

Global Pre-menstrual Syndrome Treatment Market Segmentation:

By  Drug Type, 2018–2027 ($ Millon)

  • Analgesics (pain killers)
  • Oral Contraceptive Pills (OCPs)
  • Gonadotropin-releasing Hormone (GnRH)
  • Antidepressants
  • Ovarian Suppressors
  • Diuretics
  • Benzodiazepines

By Geography, 2018-2027 ($ Millon)

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Regional Insights:

As of the current market scenario, North America and Europe together dominate the pre-menstrual syndrome treatment market due to an increase in the prevalence of premenstrual syndrome and higher awareness about PMS and prevailing treatment options. The Asia Pacific, and Middle East and Africa together present lucrative opportunities to manufacturers offering PMS treatment drugs. The large pool of females of childbearing age, growing literacy rate, and working population significantly contribute to growing opportunities in the region. Growing number of government initiatives and campaigns focusing on women and maternity health are further driving the market growth.

Market Competition Assessment:

Key players in the global pre-menstrual syndrome treatment market are Alva-Amco Pharmacal Cos., Inc., Bayer, Inc., Chattem, Inc. (Sanofi), DEKK-TEC, Inc., G. R. Lane Health Products Ltd., and others.

List of Key Companies:

  • Alva-Amco Pharmacal Cos., Inc.
  • Bayer, Inc.
  • Chattem, Inc. (Sanofi)
  • DEKK-TEC, Inc.
  • R. Lane Health Products Ltd
  • McNeil Consumer Healthcare
  • MetP Pharma AG
  • Pherin Pharmaceuticals, Inc.
  • Umecrine Mood AB
  • Novartis AG
  • GlaxoSmithKline Plc

for more information, get a report sample copy @ https://www.researchcorridor.com/request-sample/?id=144540

Key Questions Answered by Premenstrual Syndrome Market Report

  • Global premenstrual syndrome treatment market forecasts from 2020-2027
  • Regional premenstrual syndrome treatment market forecasts from 2020-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2020-2027 covering 15 major countries from the aforementioned regions
  • Premenstrual Syndrome treatment submarket forecasts from 2020-2027 covering the market by drug type, and geography
  • Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to premenstrual syndrome treatment market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level premenstrual syndrome treatment markets from 2020-2027
  • Competitive Landscape and market positioning of top 10 players operating in the premenstrual syndrome treatment market

(Reports will be updated due to COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying
Table of Content:

1. Preface
1.1. Report Scope And Description
1.1.1. Purpose Of The Report
1.1.2. Target Audience
1.1.3. Usp And Key Offering
1.2. Research Scope
1.3. Research Methodology
1.3.1. Research Methodology
1.3.2. Phase Ii – Primary Research
1.3.3. Phase Iii – Expert Panel Review
1.3.4. Assumptions
2. Executive Summary
2.1. Global Pre-Menstrual Syndrome Treatment Market Portraiture
2.2. Global Pre-Menstrual Syndrome Treatment, By Drug Type, 2019 & 2027 (Value %)
2.3. Global Pre-Menstrual Syndrome Treatment, By Geography, 2019 (Value %)
3. Pre-Menstrual Syndrome Treatment Market
3.1. Global Pre-Menstrual Syndrome Treatment Market Overview
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Growing Awareness About Pms Has Attracted The Demand For Pms Management Drugs
3.2.2. Challenges
3.2.2.1. Lack Of Social Appreciation And Attachment Of Stigma
3.2.3. Opportunities
3.2.3.1. Proliferation Of Basic Healthcare Campaigns And Initiatives
3.3. Attractive Investment Proposition, 2015
3.4. Competitive Analysis: Key Players In Mea Pre-Menstrual Syndrome Treatment Market
4. Global Pre-Menstrual Syndrome Treatment Market, By Drug Type, 2018-2027 ($ Million)
4.1. Global Pre-Menstrual Syndrome Treatment Market By Drug Type 2018-2027 ($ Million)
4.2. Analgesics (Pain Killers)
4.3. Oral Contraceptive Pills (Ocps)
4.4. Gonadotropin-Releasing Hormone (Gnrh)
4.5. Antidepressants
4.6. Ovarian Suppressors
4.7. Diuretics
4.8. Benzodiazepines
5. Global Pre-Menstrual Syndrome Treatment Market, Regional Outlook, 2018-2027 ($ Million)
5.1. Global Pre-Menstrual Syndrome Treatment By Region 2018-2027 ($ Million)
5.2. North America
5.2.1. North America Market Estimates And Forecast 2018-2027 ($ Million)
5.2.2. North America Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.2.2.1. U.S.
5.2.2.1.1. U.S. Market Estimates And Forecast 2018-2027 ($ Million)
5.2.2.2. Canada
5.2.2.2.1. Canada Market Estimates And Forecast 2018-2027 ($ Million)
5.3. Europe
5.3.1. Europe Market Estimates And Forecast 2018-2027 ($ Million)
5.3.2. Europe Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.3.2.1. Germany
5.3.2.1.1. Germany Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.3.2.2. U.K.
5.3.2.2.1. U.K. Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.3.2.3. Rest of Europe
5.3.2.3.1. Rest of Europe Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Market Estimates And Forecast 2018-2027 ($ Million)
5.4.2. Asia Pacific Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.4.3. China
5.4.3.1. China Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.4.4. Japan
5.4.4.1. Japan Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.4.5. Rest of Asia Pacific
5.4.5.1. Rest of Asia Pacific Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.5. Latin America (Latam)
5.5.1. Latin America Market Estimates And Forecast 2018-2027 ($ Million)
5.5.2. Latin America Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.5.3. Brazil
5.5.3.1. Brazil Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.5.4. Mexico
5.5.4.1. Mexico Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.5.5. Rest of Latam
5.5.5.1. Rest of Asia Pacific Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.6. Middle East And Africa (MEA)
5.6.1. Middle East And Africa (MEA) Market Estimates And Forecast 2018-2027 ($ Million)
5.6.2. Middle East And Africa (MEA) Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.6.4. South Africa
5.6.4.1. South Africa Market Estimates And Forecast By Region 2018-2027 ($ Million)
5.6.5. Rest of MEA
5.6.5.1. Rest of MEA Market Estimates And Forecast By Region 2018-2027 ($ Million)
6. Competitive Landscape
6.1. Alva-Amco Pharmacal Cos., Inc.
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. Bayer, Inc.
6.3. Chattem, Inc. (Sanofi)
6.4. Dekk-Tec, Inc.
6.5. G. R. Lane Health Products Ltd
6.6. Mcneil Consumer Healthcare
6.7. Metp Pharma AG
6.8. Pherin Pharmaceuticals, Inc.
6.9. Umecrine Mood AB
6.10. Novartis AG
6.11. Glaxosmithkline Plc
Fill the given form to inquiry before buying for Pre-menstrual Syndrome Treatment Market Report

Your Designtaion (required):

Select License Type
$3200/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client base has an annual subscription membership
  • 24x7 availability we are always there when you need us
  • 100,000+ data points in our comprehensive database
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report
For Any Assitance
Call Us: +919893685690
Contact Person: Mr. Vijendra Singh
Contact Email: sales@researchcorridor.com